UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 111

Sortiert nach

A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception

Human reproduction (Oxford), 2015-12, Vol.30 (12), p.2785-2793

2015

Volltextzugriff (PDF)

Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture

Human reproduction (Oxford), 2010-09, Vol.25 (9), p.2256-2263

2010

Volltextzugriff (PDF)

A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate

Contraception (Stoneham), 2016-04, Vol.93 (4), p.310-316

2016

Volltextzugriff (PDF)

Pituitary–ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation

Contraception (Stoneham), 2004-12, Vol.70 (6), p.442-450

2004

Volltextzugriff (PDF)

Randomized trial to evaluate contraceptive efficacy, safety and acceptability of a two-rod contraceptive implant over 4 years in the Dominican Republic

Contraception: X, 2019-01, Vol.1, p.100006-100006, Article 100006

2019

Volltextzugriff (PDF)

Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials

Contraception (Stoneham), 2002, Vol.65 (1), p.63-74

2002

Volltextzugriff (PDF)

RCT of continuous versus cyclic use of combined oral contraceptive pills

Contraception (Stoneham), 2012-09, Vol.86 (3), p.313-313

2012

Volltextzugriff (PDF)

Does meloxicam increase the incidence of anovulation induced by single administration of levonorgestrel in emergency contraception? A pilot study

Human reproduction (Oxford), 2007-02, Vol.22 (2), p.434-439

2007

Volltextzugriff (PDF)

A dose-finding, cross-over study to evaluate the effect of a transdermal Nestorone®-Estradiol (NES/E2) gel on ovulation suppression and assess acceptability in healthy ovulating women

Fertility and sterility, 2010, Vol.94 (4), p.S4-S4

2010

Volltextzugriff (PDF)

Effects of the Yuzpe regimen, given during the follicular phase, on ovarian function

Contraception (Stoneham), 2002-02, Vol.65 (2), p.121-128

2002

Volltextzugriff (PDF)

A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls

Human reproduction (Oxford), 2015-11, Vol.30 (11), p.2527-2538

2015

Volltextzugriff (PDF)

Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide

Sexually transmitted infections, 2000-12, Vol.76 (6), p.480-483

2000

Volltextzugriff (PDF)

Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants

Contraception (Stoneham), 2001-07, Vol.64 (1), p.43-49

2001

Volltextzugriff (PDF)

Emergency contraception—clinical and ethical aspects

International journal of gynecology and obstetrics, 2003-09, Vol.82 (3), p.297-305

2003

Volltextzugriff (PDF)

Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard® gel: a new formulation for “dual protection” contraception

Contraception (Stoneham), 2007-06, Vol.75 (6), p.454-460

2007

Volltextzugriff (PDF)

Risk-benefit effects of implantable contraceptives in women

Expert opinion on drug safety, 2003-05, Vol.2 (3), p.321-332

2003

Volltextzugriff (PDF)

Variations in vaginal epithelial surface appearance determined by colposcopic inspection in healthy, sexually active women

Human reproduction (Oxford), 1999-08, Vol.14 (8), p.1974-1978

1999

Volltextzugriff (PDF)

Hormonal treatment for bleeding irregularities in Norplant implant users

American journal of obstetrics and gynecology, 1996-03, Vol.174 (3), p.919-922

1996

Volltextzugriff (PDF)

Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of a multipurpose prevention vaginal ring containing tenofovir and levonorgestrel.(ORAL ABSTRACTS)

Journal of the International AIDS Society, 2021-01, Vol.24 (S1), p.16

2021

Volltextzugriff (PDF)

A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30mg ulipristal acetate

Contraception (Stoneham), 2016-04, Vol.93 (4), p.310-316

2016

Volltextzugriff (PDF)

Progestin-only contraceptive rings

Steroids, 2000-10, Vol.65 (10), p.687-691

2000

Volltextzugriff (PDF)

Local side effects observed among long-term users of norplant contraceptive implants

Contraception (Stoneham), 2003-08, Vol.68 (2), p.111-115

2003

Volltextzugriff (PDF)

Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring

Contraception (Stoneham), 1999-05, Vol.59 (5), p.311-318

1999

Volltextzugriff (PDF)

Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant implants

Human reproduction (Oxford), 1998-01, Vol.13 (1), p.188-191

1998

Volltextzugriff (PDF)

Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study

Contraception (Stoneham), 2006-08, Vol.74 (2), p.133-140

2006

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(104)

Publikationsform

Artikel
(111)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(90)
Female
(85)
Life Sciences & Biomedicine
(71)
Science & Technology
(71)
Obstetrics & Gynecology
(66)
Biological And Medical Sciences
(64)
Adult
(63)
Medical Sciences
(62)
Birth Control
(54)
Gynecology. Andrology. Obstetrics
(53)
Population
(44)
Adolescent
(36)
Levonorgestrel
(33)
Drug Implants
(31)
Other Methods Of Contraception. Sterilization
(26)
Hormonal Contraception
(25)
Contraceptive Agents, Female - Administration & Dosage
(23)
Pregnancy
(22)
Progesterone - Blood
(21)
Estradiol - Blood
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception

Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture

A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate

Pituitary–ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation

Randomized trial to evaluate contraceptive efficacy, safety and acceptability of a two-rod contraceptive implant over 4 years in the Dominican Republic

Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials

RCT of continuous versus cyclic use of combined oral contraceptive pills

Does meloxicam increase the incidence of anovulation induced by single administration of levonorgestrel in emergency contraception? A pilot study

A dose-finding, cross-over study to evaluate the effect of a transdermal Nestorone®-Estradiol (NES/E2) gel on ovulation suppression and assess acceptability in healthy ovulating women

Effects of the Yuzpe regimen, given during the follicular phase, on ovarian function

A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls

Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide

Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants

Emergency contraception—clinical and ethical aspects

Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard® gel: a new formulation for “dual protection” contraception

Risk-benefit effects of implantable contraceptives in women

Variations in vaginal epithelial surface appearance determined by colposcopic inspection in healthy, sexually active women

Hormonal treatment for bleeding irregularities in Norplant implant users

Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of a multipurpose prevention vaginal ring containing tenofovir and levonorgestrel.(ORAL ABSTRACTS)

A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30mg ulipristal acetate

Progestin-only contraceptive rings

Local side effects observed among long-term users of norplant contraceptive implants

Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring

Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant implants

Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study

Suchergebnisse filtern